CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

Altre lingue CK Life Sciences Int'l., (Holdings) Inc.

Azioni

775 KYG2176J1058

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:15 18/04/2024			Variaz. 5gg	Var. 1 gen.
0,34 ^HKD	0,00%		-10,53%	-45,16%

05/04	CK Life Sciences presenterà i dati pre-clinici di due vaccini antitumorali; le azioni salgono dell'11%	MT
19/03	CK Life Sciences Int'l., (Holdings) Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	05/04
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data	06/11
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference	01/11
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1	01/11
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3%	16/08/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	01/08/23
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023	14/03/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation	28/11/22
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation	25/11/22
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee	01/09/22
CK Life Sciences' H1 Profit Down 35%	03/08/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	02/08/22
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each	26/07/22
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022	15/03/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.	15/03/22
CK Hutchison : CK Asset profits rise in H1	05/08/21
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1	04/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CK Life Sciences Int'l., (Holdings) Inc.

Azioni

775

KYG2176J1058

Altre lingue

Filtri